Last CNY46.42 CNY
Change Today -0.25 / -0.54%
Volume 1.6M
000513 On Other Exchanges
Symbol
Exchange
Shenzhen
Hong Kong
Frankfurt
As of 3:00 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

livzon pharmaceutical grou-a (000513) Snapshot

Open
CNY46.70
Previous Close
CNY46.67
Day High
CNY46.90
Day Low
CNY46.28
52 Week High
02/19/14 - CNY55.88
52 Week Low
11/14/13 - CNY34.80
Market Cap
12.5B
Average Volume 10 Days
1.2M
EPS TTM
CNY1.63
Shares Outstanding
183.7M
EX-Date
07/25/14
P/E TM
28.5x
Dividend
CNY0.50
Dividend Yield
1.08%
Current Stock Chart for LIVZON PHARMACEUTICAL GROU-A (000513)

Related News

No related news articles were found.

livzon pharmaceutical grou-a (000513) Related Businessweek News

No Related Businessweek News Found

livzon pharmaceutical grou-a (000513) Details

Livzon Pharmaceutical Group Inc. is engaged in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. Its products primarily include Chinese and Western drug preparation products, such as Shengqi Fuzheng Injection, a series of Bismuth Potassium Citrate Granules products, anti-viral granules, Urofollitropin for injection, Menotropins for injection, Ilaprazole, Leuprorelin Acetate Microspheres for injection, Cefodizime Sodium for injection, Voriconazole for injection, and mouse nerve growth factor for injection. The company’s products also comprise bulk medicines and intermediates, including Mevastatin, Colistin, Phenylalanine, Ceftriaxone Sodium, Cefuroxime Sodium, and Cefodizime Sodium; and diagnostic reagent products, such as ELISA HIV testing reagent, MYCOII testing reagent, and TPPA testing reagent. In addition, the company provides chemical drugs, biochemical drugs, microbiological preparations, and antibiotics; polypeptide bulk medicines; diagnostic reagents and equipment; human chorionic Gonadotrophin for injection; Omeprazole Sodium for injection; Ranitidine Bismuth Citrate tablets; Valaciclovir Hydrochloride tablets; Fluvoxamine Maleate tablet; Perospirone Hydrochloride tablets; and Prostant used for the treatment of clearing away heat evil and promoting diuresis. Further, it manufactures fermented antibiotics, sterile cephalosporins, and hypolipidemic statin. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China.

Founded in 1985

livzon pharmaceutical grou-a (000513) Top Compensated Officers

President, Executive Director, Member of Nomi...
Total Annual Compensation: CNY686.4K
Chief Supervisor
Total Annual Compensation: CNY248.6K
Chief Supervisor
Total Annual Compensation: --
Supervisor
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

livzon pharmaceutical grou-a (000513) Key Developments

Livzon Pharmaceutical Group Inc. Declares Final Cash Dividend for the Year 2013, Payable on 15 August 2014

Livzon Pharmaceutical Group Inc. declared final cash dividend of CNY 0.500000000 per A share (tax included) for the year 2013 at AGM held on 30 June 2014. The final dividend will be distributed to shareholders whose names appear on the register of members of the company on 15 July 2014. The final dividend per H share is HKD 0.6299 (tax inclusive). The final dividend will be paid to H shareholders who are entitled to receive the final dividend by cheques to be dispatched by ordinary post on 15 August 2014 at their own risk.

Livzon Pharmaceutical Group Inc. Announces Management Changes

The board of directors of Livzon Pharmaceutical Group Inc. announced that Mr. Luo Xiaosong retired as an Independent Non-executive Director of the company due to the expiration of his tenure as a director, and ceased to be the Chairman of Audit Committee and a member of Remuneration and Assessment Committee of the company following his retirement. The company also announced Mr. Fu Daotian was appointed as Executive Director for the eighth session of the Board and Mr. Xu Yanjun was appointed as Independent Non-executive Director for the eighth session of the Board. Mr. Xu was appointed as the Chairman of Audit Committee and a member of Remuneration and Assessment Committee of the eighth session of the Board. Mr. Yang Liang was appointed as Secretary to the Board. Ms. Si Yanxia was appointed as Vice President and Chief Financial Officer of the company.

Livzon Pharmaceutical Group Inc. Approves Amendments to the Articles of Association

Livzon Pharmaceutical Group Inc. announced that at the Annual General Meeting held on 30 June 2014 approved amendments to the articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000513:CH CNY46.42 CNY -0.25

000513 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000513.
View Industry Companies
 

Industry Analysis

000513

Industry Average

Valuation 000513 Industry Range
Price/Earnings 28.8x
Price/Sales 2.9x
Price/Book 4.0x
Price/Cash Flow 17.8x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIVZON PHARMACEUTICAL GROU-A, please visit www.livzon.com.cn/english/. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.